Lisa Kuhns, PhD, MD

News
Increased Air Pollution Linked to AD and Chronic Inflammatory Skin Diseases
09/24/2021
According to a study published in Clinical and Experimental Dermatology, particulate matter (PM) is associated with atopic dermatitis (AD) and chronic inflammatory skin diseases in South Korea. Researchers aimed to investigate the...
According to a study published in Clinical and Experimental Dermatology, particulate matter (PM) is associated with atopic dermatitis (AD) and chronic inflammatory skin diseases in South Korea. Researchers aimed to investigate the...
According to a study published...
09/24/2021
The Dermatologist
News
Risankizumab Safe and Effective for Patients With Moderate to Severe Plaque Psoriasis Throughout a 52-Week Period
10/19/2022
Researchers aimed to assess the real-life effectiveness and safety of risankizumab.
Researchers aimed to assess the real-life effectiveness and safety of risankizumab.
Researchers aimed to assess the...
10/19/2022
The Dermatologist
News
Predicting the Survival of Patients With Head and Neck Squamous Cell Carcinoma
03/03/2023
An identified 9-gene prognostic signature based on the lysine regulators might contribute to prognosis stratification and treatment escalation for patients with head and neck squamous cell carcinoma.
An identified 9-gene prognostic signature based on the lysine regulators might contribute to prognosis stratification and treatment escalation for patients with head and neck squamous cell carcinoma.
An identified 9-gene prognostic...
03/03/2023
The Dermatologist
News
Analytical Methods Used by the FDA for Drug Approvals in 2023
10/05/2023
Utilizing robust and diverse analytical methods in 2023, the FDA ensured rigorous assessment of drug quality, safety, and efficacy in drug approval, providing reliable and effective treatments for patients, according to a study published in...
Utilizing robust and diverse analytical methods in 2023, the FDA ensured rigorous assessment of drug quality, safety, and efficacy in drug approval, providing reliable and effective treatments for patients, according to a study published in...
Utilizing robust and diverse...
10/05/2023
Pharmacy Learning Network
News
Florida Surgeon General Flags DNA Integration Risks in Pfizer and Moderna COVID-19 Vaccines, Urges FDA Action
01/24/2024
State Surgeon General Dr Joseph A. Ladapo sent a letter to the United States Food and Drug Administration (FDA) Commissioner Dr Robert M. Califf and Center for Disease Control and Prevention (CDC) Director Dr Mandy Cohen regarding questions...
State Surgeon General Dr Joseph A. Ladapo sent a letter to the United States Food and Drug Administration (FDA) Commissioner Dr Robert M. Califf and Center for Disease Control and Prevention (CDC) Director Dr Mandy Cohen regarding questions...
State Surgeon General Dr Joseph...
01/24/2024
Integrated Healthcare Executive
News
Gender, Race, Health, and Limitation Status May Help Target Interventions to Increase Physical Activity Among Patients With Asthma
12/08/2023
Targeted interventions to increase physical activity among US adults with asthma may benefit from considering gender, race, health status, and limitation status, according to a study published in the Journal of Asthma.
Targeted interventions to increase physical activity among US adults with asthma may benefit from considering gender, race, health status, and limitation status, according to a study published in the Journal of Asthma.
Targeted interventions to...
12/08/2023
First Report Managed Care
News
Antiepileptic Drugs are the Most Common Causative Agents of TEN and TEN/SJS Overlap
06/24/2021
Several drugs that have emerged since 1990 are a cause of toxic epidermal necrolysis (TEN) and TEN and Stevens-Johnson syndrome overlap.
Several drugs that have emerged since 1990 are a cause of toxic epidermal necrolysis (TEN) and TEN and Stevens-Johnson syndrome overlap.
Several drugs that have emerged...
06/24/2021
The Dermatologist
News
Patients With Uncontrolled AD Dissatisfied With Treatment Strategies
08/06/2021
Patients with uncontrolled AD are highly dissatisfied with their therapy and have a negative outlook on QOL.
Patients with uncontrolled AD are highly dissatisfied with their therapy and have a negative outlook on QOL.
Patients with uncontrolled AD...
08/06/2021
The Dermatologist
News
Dupilumab Improves Disease Severity of Alopecia Areata
09/24/2021
Dupilumab improved the severity of alopecia areata (AA) in patients with and without concomitant atopic dermatitis (AD), according to Guttman-Yassky et al in the journal Allergy. Researchers performed a phase 2a randomized clinical trial...
Dupilumab improved the severity of alopecia areata (AA) in patients with and without concomitant atopic dermatitis (AD), according to Guttman-Yassky et al in the journal Allergy. Researchers performed a phase 2a randomized clinical trial...
Dupilumab improved the severity...
09/24/2021
The Dermatologist
News
Indices of Systemic Inflammation Are Raised in Patients With Psoriasis
01/11/2023
In a case control study, researchers evaluated neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and C-reactive protein in chronic plaque psoriasis.
In a case control study, researchers evaluated neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and C-reactive protein in chronic plaque psoriasis.
In a case control study,...
01/11/2023
The Dermatologist

Upcoming Events

February 2 ⁠–⁠ February 5
LLM Winter Symposium
February 7 ⁠–⁠ February 9
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
WoundCon
May 1 ⁠–⁠ May 3
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use